ASTHAstrana Health, Inc.

$38.63

The financials

Astrana Health, Inc. by the numbers

Astrana Health, Inc. (ASTH) reported revenue of $965M in Q1 2026 (quarter ended March 31, 2026), up 56% from the same quarter a year earlier. That came with a gross margin of 11% and net income of $14M (1.5% of revenue). For the full year FY2025, revenue was $3.18B (+56% year on year) and net income $22M. Its largest product in 2026-Q1 was Health Care Capitation at $893M, 93% of the disclosed total, just ahead of Health Care Patient Service at 3.9%.

Astrana Health, Inc. income statement, Q1 2026 against the same quarter a year earlier
Income statementQ1 2026Q1 2025Change
Revenue$965M$620M+56%
Gross profit$106M$71M+48%
Operating income$29M$21M+39%
Net income$14M$6.7M+116%
Diluted EPS$0.29$0.14+107%
Revenue by product, 2026-Q1, as reported to the SEC
ProductRevenueShare
Health Care Capitation$893M93%
Health Care Patient Service$38M3.9%
Management Service$16M1.6%
Health Care Other$12M1.3%
Product And Service Other$6.2M0.6%

Business Segments

Revenue split by product segment, from SEC XBRL filings.

Latest period: Q1 2026Total $965.1M (+0.95%)
Management Service grew +579% year on yearHealth Care Other -14% year on year
  • Health Care Capitation$892.9MQoQ +3.4%year on year +53%
  • Health Care Patient Service$37.8MQoQ -5.6%year on year +154%
  • Management Service$15.7MQoQ +3.1%year on year +579%
  • Health Care Other$12.5MQoQ -59%year on year -14%
  • Product And Service Other$6.2MQoQ -5.8%year on year +31%
Segment sum = 100% of reported consolidated revenue · Latest source: 10-Q filed 2026-05-08, SEC EDGAR